METTL1 and glioma: Elevated levels of METTL1 correlates with poor prognosis of various cancers, including bladder cancer (BLCA) (18, 19), hepatocellular carcinoma (HCC) (15, 20), lung cancer (8), colon cancer (21), liver cancer (22), and glioma (23).